We already knew Rush’s Tower is a great building, but we still were a little awed by the company it’s now in: A group of eight stunning buildings that the American Institute of Architects (AIA) selected as the 2014 recipients of the annual AIA National Healthcare Design Awards.
These buildings represent “the best in healthcare design,” according to the AIA, which announced the awards at the end of July. “These projects exhibit conceptual strengths that solve aesthetic, civic, urban, and social concerns as well as the requisite functional and sustainability concerns of a hospital.” (Founded in 1857, the AIA is a Washington, D.C.-based professional association for architects and their partners.)
Even the swanky design magazine Architectural Digest was impressed. It featured the Tower and the other award winners in this awesome slideshow on its “Daily AD” blog.
The buildings “push the boundaries of design to create uplifting spaces that are sensitive to the needs of patients and their families. It’s no easy feat,” blogger Asad Syrkett proclaimed.
Of course, these honors are nothing new. Last year, the Tower received the top award in the health category at the 2013 World Architecture Festival. It also was included as a finalist in two other prestigious international architecture competitions – the World Architecture News Award and the Council on Tall Buildings and Urban Habitat’s Best Tall Buildings Award. In 2012, the Tower was one of only 10 health care projects in the world listed in global consultancy KPMG’s showcase of the 100 most innovative and inspiring urban infrastructure projects from around the world.
We’re glad to see the Tower get so much attention. We’re also thrilled it’s ranked among such great buildings. Give them a look.
Rush University Medical Center once again has been named one of the nation’s top hospitals, according to the new issue of U.S. News & World Report. Rush is ranked in seven of 16 categories included in the magazine’s 2014 -15 “America’s Best Hospitals” issue, which became available online on July 15, and is one of the two top-ranked hospitals in Illinois overall.
Rush’s orthopedics program was ranked No. 6 nationwide, making it the highest ranked orthopedics program in Illinois. Rush’s other ranked programs were geriatrics (No. 17); neurology and neurosurgery (No. 17); nephrology (No. 31); urology (No. 43); cardiology and heart surgery (No. 46); and cancer (No. 48).
U.S. News also noted that the following Rush specialty services are “high-performing”: diabetes and endocrinology; ear, nose and throat; gastroenterology; gynecology; and pulmonary.
Rush University Medical Center has been named one of only 20, advanced “Most Wired” hospitals in the nation, according to the 16th annual survey conducted by Hospitals & Health Networks.
Out of 680 participants, Rush was one of only 20 organizations who met the criteria to be considered for “Most Wired–Advanced Organizations.” To make the advanced list, an organization must show exceptional results in the Most Wired Survey and Benchmarking Study.
The survey focused on health care systems and hospitals throughout the nation using clinical information systems that improve and enhance patient care and the patient experience. The 2014 Most Wired survey is published in the July issue of the magazine.
“This recognition reflects Rush’s deep commitment to use information technology (IT) that engages our patients, maximizes quality, safety, and efficiency of care, and help connect Rush with our broader health care community,” said Dr. Shannon Sims, PhD, associate chief medical information officer at Rush University Medical Center.
Nearly 67 percent of Most Wired hospitals share critical patient information electronically with specialists and other care providers. Most Wired hospitals use information technology to reduce the likelihood of medical errors. For example, at Most Wired hospitals, 81 percent of medications are matched to the patient, nurse and order using bar code technology at the bedside.
Until 2006, Stephanie Krienitz never had traveled outside the U.S. Since then, she’s made eight trips to foreign countries to perform volunteer work, including three medical missions to the Philippines, while also working as a nurse at Rush University Medical Center.
In recognition of her service at Rush and around the world, the American Red Cross of Greater Chicago has chosen Krienitz to receive its 2014 Nurse Hero award. She was one of the honorees at the Red Cross’ Heroes Breakfast held on April 30 in Chicago.
“It’s not heroic, anything I’ve done. It’s more of a pleasure and a privilege that I get to do it,” Krienitz says. “It’s a fulfilling job helping other people, and it’s really cool when you get to do that job outside your normal arena and see how different things are in other parts of the world.”
Krienitz made the first of her trips to the Philippines in 2006 and the third in early 2013. The trips were arranged by Calvary Church of Naperville, of which she is a member, and led by Filipino physician who also is a member of the congregation.
A recently FDA-approved device has been shown to reduce seizures in patients with medication-resistant epilepsy by as much as 50 percent. When coupled with an innovative electrode placement planning system developed by physicians at Rush, the device facilitated the complete elimination of seizures in nearly half of the implanted Rush patients enrolled in the decade-long clinical trials.
That’s good news for a large portion of the nearly 400,000 people in the U.S. living with epilepsy whose seizures can’t be controlled with medications and who are not candidates for brain surgery.
Epilepsy is a chronic neurological condition characterized by recurrent seizures that disrupt the senses, or can involve short periods of unconsciousness or convulsions. “Many people with epilepsy have scores of unpredictable seizures every day that make it impossible for them to drive, work or even get a good night’s sleep,” said Dr. Marvin Rossi, co-principal investigator of the NeuroPace Pivotal Clinical Trial and assistant professor of neurology at the Rush Epilepsy Center.
The NeuroPace RNS System uses responsive, or ‘on-demand’ direct stimulation to detect abnormal electrical activity in the brain and deliver small amounts of electrical stimulation to suppress seizures before they begin.
A Rush University graduate student has committed to run 54 miles on Saturday in honor of her professor’s late mother, Kathleen Mai, who died from idiopathic pulmonary fibrosis (IPF), an incurable lung disease that results in deep tissue thickening and stiffening. The 5k/10k run and walk will be held at the Danada Equistrian Track in Wheaton, Ill., on Saturday, April 19 at 10 a.m.
The student, Sarah Brundidge, committed to run 54 miles—one mile for each year Mai lived—to raise funds for respiratory care research. The run is a fundraising event for the Kathleen Mai Research Fund, established to support student research projects in respiratory.
Mai’s daughter, Meagan Dubosky, assistant professor of respiratory care at Rush, established the fund along with the help of members from the respiratory care program’s student government. To date, more than $34,000 has been raised.
Children’s half-mile run/walk and Easter egg hunt to follow at 1 p.m. The last leg of Brundidge’s epic run will be around 2 p.m.
Infections caused by a specific type of antibiotic-resistant bacteria are on the rise in U.S. children, according to new study published in the Journal of the Pediatric Infectious Diseases Society. While still rare, the bacteria are increasingly found in children of all ages, especially those 1-5 years old, raising concerns about dwindling treatment options.
“Some infections in children that have typically been treated with oral antibiotics in the past may now require hospitalization, treatment with intravenous drugs, or both, as there may not be an oral treatment option available,” said Dr. Latania K. Logan, lead author of the study and an assistant professor of pediatrics and pediatric infectious disease specialist at Rush University Medical Center.
The team of researchers led by Logan analyzed resistance patterns in approximately 370,000 bacterial cultures from pediatric patients collected nationwide between 1999 and 2011.
They found that the prevalence is increasing in a resistant type of bacteria, which produces a key enzyme, extended-spectrum beta-lactamase (ESBL), that thwarts many strong antibiotics, making them ineffective.